Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Reported Basic Consolidated EPS Of $-0.6684 For Period Ended 2015-08-31

0

The annual basic consolidated EPS for Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) for the period ended 2015-08-31 was $-0.6684. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-08-31 was $-0.6684.

EPS from continuing operations

Coming to basic EPS from continuing operations, Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) reported $-0.6684 for the annual period ended 2015-08-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-08-31 stood at $-0.6684.

EPS contribution from parent

For the annual period ended 2015-08-31, Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) received basic EPS of $-0.6684 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-08-31 was $-0.6684.

Basic net EPS

For the annual period ended 2015-08-31, Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) reported basic net EPS of $-0.67. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-08-31 stood at $-0.67.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-08-31 stood at $-0.6684. For the quarter ended 2015-08-31, consolidated diluted EPS was $-0.6684.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-0.6684 for the period ended 2015-08-31. Diluted EPS from continuing operations for the quarter ended 2015-08-31 was $-0.6684.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-08-31 was $-0.67. For the quarterly period ended 2015-08-31, net diluted EPS was $-0.67.

Diluted EPS from parent

From the parent company, Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) received diluted EPS of $-0.6684 for the annual period ended 2015-08-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-08-31 was $-0.6684.

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) posted net basic EPS reading of $-0.67 for the annual period ended 2015-08-31. For the quarter, basic net EPS of $-0.67 was for the quarter ended 2015-08-31.

Net diluted EPS for Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) for the annual period ended 2015-08-31 was $-0.67. The company also reported net diluted EPS reading of $-0.67 for the quarter ended 2015-08-31.

The annual average basic shares outstanding for the period ended 2015-08-31 is 10.821 while for the quarter ended 2015-08-31 is 10.821.

The diluted shares outstanding for the fiscal year ended is 2015-08-31 is 10.821 while for the quarter ended 2015-08-31 is 10.821.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 39 times, 1 visits today)